ArticleRespiratory research2025

An orally bioavailable BRD4 inhibitor disrupts expansion of a pathogenic epithelial-mesenchymal niche in bleomycin-induced fibrosis.

Melissa Skibba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.